Spain Probiotics Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Ingredient (Bacteria, Yeast), By Form (Liquid, Dry) And By Application (Functional Food And Beverages, Dietary Supplements, Animal Feed), And By End-User (Human, Animal) - Forecasts From 2020 To 2025

Published:  Jun 2020 Report Code: KSI061613232 Pages: 75

Spain Probiotics Market is expected to grow at a compound annual growth rate of 3.09%over the forecast period to reach a market size of US$ 1,342.632million in 2025 from US$ 1,118.577million in 2019. The rise of convenience snacking has led to the supplementing of one’s diet with highly processed food that has eventually led to a rise in non-communicable diseases in affluent nations. the improper balance of protein, fat, and carbohydrate has been increasingly linked with the development of chronic and systemin ailments. Easy access to food from supermarkets has distorted the very idea of what farm to fork once meant.  Thus, consumers are becoming increasingly aware of the impacts of these habits. Therefore, in cognizance of this consumer trend that is surging upward, various developments have taken place in the Spain Probiotics Market. In May 2019, OptiBiotix Health announced that it will be involving its Lactobacillus Plantarum (LPLDL) probiotic strain as the UK-based firm signed a license agreement with a Spanish personalized nutrition firm Spanish Institute of Personalised Nutrition (IENP). It was a three-year agreementa deal that grants them non-exclusive rights to manufacture and market food supplements containing OptiBiotix LPLDL in Spain.LPLDL is one of severalOptiBiotix products, offering a natural, scientifically-backed alternative to improve blood lipid proles, blood pressure, and cholesterol levels without known side effects. Further in September 2019, because of Kaneka’s interest in involving health and nutrition firms, it has acquired the Spanish based AB-Biotics which among others had business activities in probiotics that included a collection of bacterial strains contains more than 550 different wild-type strains that are used to address Irritable Bowel Syndrome (IBS), reduce LDL- cholesterol and triglyceride levels and infant colic within its ambit.

Beside human consumption, the upward trend in pig meat production continued to boost the growth of the market during the forecast period. This also creates a fertile opportunity for inclusion probiotics in animal feed. Further, pig Production practices in Spain are changing to meet new regulatory and welfare requirements simultaneously employing an integrated model and focus on the export market.  In recent times, it has been reutilized that supporting the development of a healthy gut in pigs does not rely on antibiotic use, but changes in nutrition and management may be needed and after a series of trials it was found out that the inclusion of probiotics in pig feed of weight gain and decreased mortality to young animals in specific circumstances. Moreover, Spain accounts for 16% of main sheep meat-producing member states of the EU subsequently offsetting the decline in sheep meat production elsewhere due to the rise in the same by 3.9%, in 2018 [Source: Agriculture, forestry and fisheries in the EU: key messages, EUROSTAT]. These developments are poised to fuel a healthy growth of the market during the forecast period.


  • By Application
    • Functional Food and Beverages
    • Dietary Supplements
    • Animal Feed
  • By End-User
    • Human
    • Animal
  • By Ingredient
    • Bacteria
      • Lactobacilli
      • Bifidobacterium
      • Streptococcus Thermophilus
    • Yeast
      • Saccharomyces Boulardii
      • Others
  • By Function
    • Regular
    • Preventative Healthcare
    • Therapeutic
  • By Type
    • Lactobacillus
    • Streptococcus
    • Bifidobacterium
    • Spore Formers
    • Others
  • By Form
    • Liquid
    • Dry
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Spain Probiotics Market, By Application
5.1. Introduction
5.2. Functional Food and Beverages
5.3. Dietary Supplements
5.4. Animal Feed
6. SpainProbiotics Market, By End-User
6.1. Introduction
6.2. Human
6.3. Animal
7. SpainProbiotics Market, By Ingredients
7.1. Introduction
7.2. Bacteria
7.2.1. Lactobacilli
7.2.2. Bifidobacterium
7.2.3. Streptococcus Thermophilus 
7.2.4. Others
7.3. Yeast
7.3.1. Saccharomyces Boulardii
7.3.2. Others
8. SpainProbiotics Market, By Function
8.1. Introduction
8.2. Regular
8.3. Preventative Healthcare
8.4. Therapeutic
9. SpainProbiotics Market, By Type
9.1. Introduction
9.2. Lactobacillus
9.3. Streptococcus
9.4. Bifidobacterium
9.5. Spore Formers
9.6. Others
10. SpainProbiotics Market, By Form
10.1. Introduction
10.2. Liquid
10.3. Dry
11. Competitive Environment and Analysis
11.1. Major Players and Strategy Analysis
11.2. Emerging Players and Market Lucrativeness
11.3. Mergers, Acquisitions, Agreements, and Collaborations
11.4. Vendor Competitiveness Matrix
12. Company Profiles
12.1. Archer 
12.2. Yakult
12.3. Nestle
12.4. Danone
12.5. Probi AB
12.6. Pepsico




Probi AB



Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


We are in compliance with the global privacy laws.

Connect With Us